Research programme: fungal allergy vaccine - AlerGenetica
Latest Information Update: 18 Jul 2016
At a glance
- Originator AlerGenetica
- Class Fungal allergy immunotherapies; Peptide vaccines
- Mechanism of Action Immunomodulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Allergic asthma; Allergic rhinitis
Most Recent Events
- 18 Jul 2016 Preclinical trials in Allergic rhinitis in Spain (unspecified route)
- 18 Jul 2016 Preclinical trials in Allergic asthma in Spain (unspecified route)